本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ensysce Biosciences Inc.

0.4869
-0.0290-5.62%
盤後0.49000.0031+0.64%19:53 EDT
成交量:56.27萬
成交額:28.16萬
市值:947.35萬
市盈率:-0.18
高:0.5230
開:0.5200
低:0.4769
收:0.5159
52周最高:2.75
52周最低:0.2300
股本:1,945.68萬
流通股本:1,837.90萬
量比:0.69
換手率:3.06%
股息:- -
股息率:- -
每股收益(TTM):-2.7523
每股收益(LYR):-3.9790
淨資產收益率:-1295.09%
總資產收益率:-185.51%
市淨率:-12.12
市盈率(LYR):-0.12

資料載入中...

2022/01/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/27

重要事件披露

8-K - Current report
2022/01/18

重要事件披露

8-K - Current report
2021/12/27

重要事件披露

8-K - Current report
2021/11/01

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/29

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/25

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/10/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/07

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/09/27

重要事件披露

8-K - Current report
2021/09/22

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/17

重要事件披露

8-K - Current report
2021/08/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/09

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/07/21

重要事件披露

8-K - Current report
2021/07/12

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/12

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/12

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/12

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership